发明公开
EP2358757A1 ANTIVIRAL VACCINES WITH IMPROVED CELLULAR IMMUNOGENICITY
审中-公开
ANTIVIRALE IMPFSTOFFE MITERHÖHTERZELLIMMUNOGENITÄT
- 专利标题： ANTIVIRAL VACCINES WITH IMPROVED CELLULAR IMMUNOGENICITY
- 专利标题（中）： ANTIVIRALE IMPFSTOFFE MITERHÖHTERZELLIMMUNOGENITÄT
-
申请号： EP09828172.8申请日： 2009-11-18
-
公开(公告)号： EP2358757A1公开(公告)日： 2011-08-24
- 发明人: BAROUCH, Dan, H. , KORBER, Bette, T. , FISCHER, William, M.
- 申请人： Beth Israel Deaconess Medical Center , Los Alamos National Laboratory
- 申请人地址： 330 Brookline Avenue Boston, MA 02215 US
- 专利权人： Beth Israel Deaconess Medical Center,Los Alamos National Laboratory
- 当前专利权人： Beth Israel Deaconess Medical Center,Los Alamos National Laboratory
- 当前专利权人地址： 330 Brookline Avenue Boston, MA 02215 US
- 代理机构： Lahrtz, Fritz
- 优先权： US248188P 20091002; US115703P 20081118; US152184P 20090212
- 国际公布： WO2010059732 20100527
- 主分类号： C07K17/00
- IPC分类号： C07K17/00
摘要：
The invention provides compositions, methods, and kits for the treatment or prevention of viral infections. The polyvalent (e.g., 2-valent) vaccines described herein incorporate computationally-optimized viral polypeptides that can increase the diversity or breadth and depth of cellular immune response in vaccinated subjects.
公开/授权文献
- EP2358757B1 ANTIVIRAL VACCINES WITH IMPROVED CELLULAR IMMUNOGENICITY 公开/授权日：2018-09-12
信息查询
